Lu's breast cancer dataset with 129 samples [28] showed a higher expression of H19 in ERα-positive (n = 76) than ERα-negative (n = 53) breast cancers (Figure 6A), which suggested a possible involvement of ERα in the upregulation of H19 in chemoresistant cancer cells. The gene discussed is H19; the disease is breast carcinoma.